Harrison Dermatology & Research Group

Harrison Dermatology & Research Group is a specialized medical practice and clinical research organization based in Missouri City, Texas. Led by Dr. Harrison Nguyen, a double board-certified dermatologist and Mohs surgeon, the group provides comprehensive dermatological care, including Mohs micrographic surgery and medical aesthetics. The organization serves as a high-volume clinical trial site for Phase 1-4 studies, collaborating with global pharmaceutical leaders such as AbbVie, Novartis, and UCB to evaluate novel biologics and small molecules. Additionally, the group is a leader in dermatologic oncology research, focusing on the clinical integration of gene expression profile (GEP) testing for skin cancer risk stratification. By bridging the gap between academic research and private practice, the group offers patients access to cutting-edge therapies for chronic inflammatory skin conditions.